The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Research Grant, 2018Developing New 18F-based Brain Tracers for Imaging Nerve Interactions (Synapses) in the Human Brain
Study Rationale:
A synapse is a structure that allow nerve cells (i.e., neurons) to communicate with one-another or with target cells. Changes in synaptic density are associated with a variety of... -
Inflammation Biomarkers Program, 2018Alpha-Synuclein and Auto-antibodies in a Stratified Prodromal Cohort
Study Rationale:
Previous studies have shown that the body's immune response is involved in Parkinson's disease. This includes inflammation in the brain as well as systemic inflammation. One recent... -
Research Grant, 2018Parkinson's Disease Progression Model
Study Rationale:
The rich and longitudinal (gathered over time) dataset available through the Parkinson's Progression Markers Initiative provides a unique opportunity to gain insights into the... -
Therapeutic Pipeline Program, 2018Discovery and Development of Novel Parkin Activators
Study Rationale:
Parkinson's disease is characterized by a loss of nerve cells (neurons) in the brain resulting potentially from their inability to remove damaged mitochondria, which control energy... -
Research Grant, 2018Developing Biosignatures of Parkinson's Disease Using Sense of Smell Supplement
Promising Outcomes of Original Grant:
Recent reports of people with “super-smelling powers” have triggered the idea that there exists a specific scent in Parkinson’s patients’ sebum, an oily skin... -
Target Advancement Program, 2018Evaluation of PARIS ASOs in Models of Parkinson's Disease
Study Rationale:
The parkin-interacting substrate (PARIS) prevents genes that are important in the survival of dopamine neurons from working by limiting their expression in neurons. Previously we...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.